LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 22.2

Change

-0.40 (-1.77)%

Market Cap

N/A

Volume

101.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.46 (-1.46%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.22 (-0.78%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.67 (+2.62%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.92 (-2.75%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.40 (-0.87%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.70 (+2.39%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.05 (+0.46%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.15 (-0.64%)

CAD 2.78B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.11% 36% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.11% 36% F 33% F
Trailing 12 Months  
Capital Gain -8.75% 11% F 20% F
Dividend Return 5.26% 88% B+ 85% B
Total Return -3.49% 16% F 22% F
Trailing 5 Years  
Capital Gain -9.98% 15% F 21% F
Dividend Return 32.97% 84% B 74% C
Total Return 22.99% 36% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 2.17% 43% F 41% F
Dividend Return 3.09% 45% F 37% F
Total Return 0.92% 79% B- 36% F
Risk Return Profile  
Volatility (Standard Deviation) 5.99% 75% C 88% B+
Risk Adjusted Return 51.58% 58% F 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.